These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28738534)

  • 1. High expression of CD47 predicts adverse prognosis in Chinese patients and suppresses immune response in melanoma.
    Fu W; Li J; Zhang W; Li P
    Biomed Pharmacother; 2017 Sep; 93():1190-1196. PubMed ID: 28738534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Expression of CD47 and CD68 in Breast Carcinoma and Their Prognostic Value.
    Alhanafy S; Hany H; Nasef K; El-Salkh I; Elhawary A
    Asian Pac J Cancer Prev; 2024 Jul; 25(7):2515-2527. PubMed ID: 39068587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
    Shimizu A; Sawada K; Kobayashi M; Yamamoto M; Yagi T; Kinose Y; Kodama M; Hashimoto K; Kimura T
    Mol Cancer Res; 2021 Sep; 19(9):1583-1595. PubMed ID: 34016744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts.
    Ngo M; Han A; Lakatos A; Sahoo D; Hachey SJ; Weiskopf K; Beck AH; Weissman IL; Boiko AD
    Cell Rep; 2016 Aug; 16(6):1701-1716. PubMed ID: 27477289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis.
    Liu R; Wei H; Gao P; Yu H; Wang K; Fu Z; Ju B; Zhao M; Dong S; Li Z; He Y; Huang Y; Yao Z
    Oncotarget; 2017 Jun; 8(24):39021-39032. PubMed ID: 28380460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD47 expression and CD163
    Imam R; Chang Q; Black M; Yu C; Cao W
    BMC Cancer; 2021 Mar; 21(1):320. PubMed ID: 33765961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and Prognostic Significance of CD47-SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer.
    Sugimura-Nagata A; Koshino A; Inoue S; Matsuo-Nagano A; Komura M; Riku M; Ito H; Inoko A; Murakami H; Ebi M; Ogasawara N; Tsuzuki T; Takahashi S; Kasugai K; Kasai K; Inaguma S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Analysis of Phagocytic and Immunomodulatory Markers in Cervical Cancer Reveals Constellations of Potential Prognostic Relevance.
    Yordanov A; Damyanova P; Vasileva-Slaveva M; Hasan I; Kostov S; Shivarov V
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis.
    Wang Y; Xu Z; Guo S; Zhang L; Sharma A; Robertson GP; Huang L
    Mol Ther; 2013 Oct; 21(10):1919-29. PubMed ID: 23774794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.
    Yoshida K; Tsujimoto H; Matsumura K; Kinoshita M; Takahata R; Matsumoto Y; Hiraki S; Ono S; Seki S; Yamamoto J; Hase K
    Cancer Med; 2015 Sep; 4(9):1322-33. PubMed ID: 26077800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration.
    Shi M; Gu Y; Jin K; Fang H; Chen Y; Cao Y; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Qin J; Li R; Zhang H; Zhang W
    Cancer Immunol Immunother; 2021 Jul; 70(7):1831-1840. PubMed ID: 33389016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade.
    Anderson KL; Snyder KM; Ito D; Lins DC; Mills LJ; Weiskopf K; Ring NG; Ring AM; Shimizu Y; Mescher MF; Weissman IL; Modiano JF
    Melanoma Res; 2020 Apr; 30(2):147-158. PubMed ID: 31205227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors.
    Orozco-Morales M; Avilés-Salas A; Hernández-Pedro N; Catalán R; Cruz-Rico G; Colín-González AL; Dosal-Mancilla E; Barrios-Bernal P; Arrieta O
    J Immunol Res; 2021; 2021():6632249. PubMed ID: 34195295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive analysis of CD47 expression in various histological subtypes of soft tissue sarcoma: exploring novel opportunities for macrophage-directed treatments.
    Benesova I; Capkova L; Ozaniak A; Pacas P; Kopeckova K; Galova D; Lischke R; Buchler T; Ozaniak Strizova Z
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):134. PubMed ID: 38493445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD47 promotes cell growth and motility in epithelial ovarian cancer.
    Wang CL; Lin MJ; Hsu CY; Lin HY; Tsai HP; Long CY; Tsai EM; Hsieh TH; Wu CH
    Biomed Pharmacother; 2019 Nov; 119():109105. PubMed ID: 31493748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic and Prognostic Significance of CD47 Expression and Tumor-associated Macrophages in Endometrial Carcinoma.
    Sercan Ç; Haberal Reyhan AN; Özen Ö; Ayhan A
    Int J Gynecol Pathol; 2022 Jul; 41(4):397-406. PubMed ID: 34282107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD47 is not Over-Expressed in Fibrolamellar Hepatocellular Carcinoma.
    Cooney T; Wei MC; Rangaswami A; Xu L; Sage J; Hazard FK
    Ann Clin Lab Sci; 2017 Aug; 47(4):395-402. PubMed ID: 28801364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies.
    Dheilly E; Moine V; Broyer L; Salgado-Pires S; Johnson Z; Papaioannou A; Cons L; Calloud S; Majocchi S; Nelson R; Rousseau F; Ferlin W; Kosco-Vilbois M; Fischer N; Masternak K
    Mol Ther; 2017 Feb; 25(2):523-533. PubMed ID: 28153099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models.
    Xu JF; Pan XH; Zhang SJ; Zhao C; Qiu BS; Gu HF; Hong JF; Cao L; Chen Y; Xia B; Bi Q; Wang YP
    Oncotarget; 2015 Sep; 6(27):23662-70. PubMed ID: 26093091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.